Similar to breast cancer, in prostate cancer nuclear IKKα appears to provide a mechanism for hormone resistance as IKKα is associated with the development of castrate-resistant prostate cancer [53] and deletion of BAG3 which is required for IKKα nuclear translocation delays development of castrate-resistant disease [88]. Here, CHUK is linked to breast carcinoma.